detox adjuvant: Clinical Trials

7 trials of detox adjuvant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 unknown. 3 Phase 1, 2 Not applicable, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Not applicable2Completed 2
Phase 32Completed 1, Unknown 1
Phase 21Completed 1

Follow detox adjuvant: new trials by email Literature Review of detox adjuvant trials Research Report on detox adjuvant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Investigation Into a 21-Day Detoxification Diet With a Seven-Day Continuation
21-Day Detox and Green Drink supplement - Detoxification
Not applicableCompletedChef V, LLC382022-12-022023-05-15
Effect of an Innovative Online Ayurveda Program on the Mental and Physical Health of Home-Based Adults
Online Ayurveda Program for Detox and Lifestyle - Anxiety, Depression
Not applicableCompletedMaharishi International University982021-03-102024-12-09
Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients
DNA Vaccine, Cyclophosphamide - Head and Neck Cancer
Phase 1TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins22012-04-012018-11-23
Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
Detox-B adjuvant, verteporfin - Melanoma (Skin)
Phase 1 / Phase 2CompletedQLT Inc.2000-10-012013-11-06
Vaccine Therapy in Treating Women With Metastatic Breast Cancer
Detox-B adjuvant, THERATOPE STn-KLH vaccine, keyhole limpet hemocyanin - Breast Cancer
Phase 3CompletedOncothyreon Canada Inc.9501999-01-012013-03-26
Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
Detox-B adjuvant, recombinant interferon alfa - Melanoma (Skin)
Phase 3UnknownGlaxoSmithKline3001996-01-012014-01-06
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Detox-B adjuvant, ras peptide cancer vaccine - Recurrent Colon Cancer, Extensive Stage Small Cell Lung Cancer
Phase 1CompletedNational Cancer Institute (NCI)1995-03-012024-03-04

Conditions studied

Melanoma (2)  ·  Anxiety Disorders (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Depression (1)  ·  Gastrointestinal Neoplasms (1)  ·  Genetic Diseases, Inborn (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Sexually Transmitted Diseases, Viral (1)

Sponsors

Chef V, LLC (1)  ·  GlaxoSmithKline (1)  ·  Maharishi International University (1)  ·  National Cancer Institute (NCI) (1)  ·  Oncothyreon Canada Inc. (1)  ·  QLT Inc. (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Countries

United States (5)  ·  Austria (1)  ·  Canada (1)

Top investigators

Graeme R. Boniface, PhD (1)  ·  Joseph Califano, MD (1)  ·  Kenneth B. Von Eschen, PhD (1)  ·  Samir N. Khleif (1)  ·  Viktoria Luhaste, PhD (1)

Results publications

PMID 23983823

NIH funding

P50DE019032 (1)